You Make the Call

You Make the Call

Each month we’ll pick a challenging clinical question submitted through the Consult-a-Colleague program and post the expert’s response.

You Make the Call

You Make the Call: Which direct oral anticoagulant would you choose for a saddle...

This month, Allyson Pishko, MD, MSCE, discusses choice of direct oral anticoagulant (DOAC) for a saddle pulmonary embolism. And don't forget to check out next...
You Make the Call

You Make the Call: How would you treat this patient with JAK2-positive essential thrombocythemia?

This month, Ruben Mesa, MD, discusses anticoagulation in a patient with essential thrombocythemia. And don't forget to check out next month's clinical dilemma - send...
You Make the Call

You Make the Call: Can I start cytoreductive therapy in a patient with low-risk...

This month, Ayalew Tefferi, MD, discusses cytoreductive therapy in a patient with low-risk polycythemia vera. And don't forget to check out next month's clinical dilemma...
You Make the Call

You Make the Call: Is hypogammaglobulinemia alone an indication for treatment for CLL?

This month, Ariela Noy, MD, discusses whether hypogammaglobulinemia alone is an indication for treatment of CLL. And don't forget to check out next month's clinical...
You Make the Call

You Make the Call: Is 3 months of anticoagulation enough for a provoked VTE?

This month, Keith McCrae, MD, discusses the appropriate length of anticoagulation for a provoked DVT. And don't forget to check out next month's clinical dilemma...
You Make the Call

You Make the Call: Should a pregnant patient with hemochromatosis receive iron?

This month, Tomas Ganz, MD, PhD, discusses the treatment of iron deficiency during pregnancy in a patient with hereditary hemochromatosis. And don't forget to check...
You Make the Call

You Make the Call: Is warfarin recommended for a patient with recurrent coronary artery closure?

This month, Michael Kroll, MD, discusses management of a patient with recurrent coronary artery closure. And don’t forget to check out next month’s clinical dilemma – send in...
You Make the Call

You Make the Call: Should this patient with DLBCL receive rituximab maintenance after R-CHOP?

This month Ann S. LaCasce, MD, MMSc, discusses whether a patient with high-risk DLBCL should receive rituximab maintenance after R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride,...
You Make the Call

You Make the Call: How would you treat these patients with acute stroke who...

This month Keith R. McCrae, MD, discusses anticoagulation for patients with antiphospholipid antibodies and a history of stroke. And don't forget to check out next month's...
You Make the Call

You Make the Call: Would rituximab re-treatment help this patient with hemolytic anemia?

This month, Edward Benz Jr., MD, discusses treatment of Coombs-positive hemolytic anemia in a patient who declines to undergo splenectomy.I am caring for a...
Advertisement

Current Issue

January 2021 Annual Meeting Edition

This issue features highlights from the 2020 ASH Annual Meeting, a look at patient holiday gift customs around the world, and more.

Block title